{
  "trial_id": "NCT00980161",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Treatment na\u00efve",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Age 18 and older than 18 years old",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Anti-HCV (Abbott HCV EIA 2.0, Abbott Diagnostic, Chicago, IL) positive > 6 months",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Detectable serum quantitative HCV-RNA (Cobas Taqman v2.0, Roche Diagnostics)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Serum alanine aminotransferase levels above the upper limit of normal with 6 months of enrollment",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "A liver biopsy consistent with the diagnosis of chronic hepatitis C",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Receive 24 or 48 weeks of PEG-IFN alfa plus ribavirin (1,000 mg/day for BW < 75 kg; 1,200 mg/day for BW \u2265 75 kg for HCV genotype 1; 800 mg/day for HCV genotype 2)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Age 18 and older than 18 years old",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Anti-HCV (Abbott HCV EIA 2.0, Abbott Diagnostic, Chicago, IL) positive > 6 months",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Detectable serum quantitative HCV-RNA (Cobas Taqman v2.0, Roche Diagnostics)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Serum alanine aminotransferase levels above the upper limit of normal with 6 months of enrollment",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "A liver biopsy consistent with the diagnosis of chronic hepatitis C",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Anemia (hemoglobin < 13 gram per deciliter for men and < 12 gram per deciliter for women)",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Neutropenia (neutrophil count <1,500 per cubic milliliter)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Thrombocytopenia (platelet <90,000 per cubic milliliter)",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Co-infection with hepatitis B virus (HBV) or human immunodeficiency virus (HIV)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Mixed HCV genotype 1 with other genotype infection",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Chronic alcohol abuse (daily consumption > 20 gram per day)",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Decompensated liver disease (Child-Pugh class B or C)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Serum creatinine level more than 1.5 times the upper limit of normal",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has chronic HCV infection and is on combination therapy with IFN and RBV for the past 9 months.",
  "_meta": {
    "topic_id": "27",
    "trial_id": "NCT00980161",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}